Chemoinformaics analysis of Benzyl 2-hydroxy-6-methoxybenzoate
| Molecular Weight | 258.273 | nRot | 4 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 13 |
| Exact Molecular Weight | 258.089 | nRing | 2 |
| Solubility: LogS | -3.35 | nHRing | 0 |
| Solubility: LogP | 3.261 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 37.5931 |
| nHD | 1 | BPOL | 18.3849 |
| QED | 0.857 |
| Synth | 1.675 |
| Natural Product Likeliness | 0.051 |
| NR-PPAR-gamma | 0.315 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.708 |
| MDCK | 0.0000311 |
| BBB | 0.574 |
| PPB | 0.968015 |
| VDSS | 0.782 |
| FU | 0.0403837 |
| CYP1A2-inh | 0.988 |
| CYP1A2-sub | 0.781 |
| CYP2c19-inh | 0.961 |
| CYP2c19-sub | 0.134 |
| CYP2c9-inh | 0.825 |
| CYP2c9-sub | 0.829 |
| CYP2d6-inh | 0.907 |
| CYP2d6-sub | 0.712 |
| CYP3a4-inh | 0.593 |
| CYP3a4-sub | 0.298 |
| CL | 13.029 |
| T12 | 0.813 |
| hERG | 0.082 |
| Ames | 0.101 |
| ROA | 0.014 |
| SkinSen | 0.453 |
| Carcinogencity | 0.544 |
| EI | 0.983 |
| Respiratory | 0.057 |
| NR-Aromatase | 0.029 |
| Antiviral | No |
| Prediction | 0.719728 |